Emerging treatments for navicular syndrome offer welfare improvements through better pain management and structural support.
Navicular syndrome welfare management has improved substantially with the development of targeted imaging allowing treatment matched to specific pathology rather than empirical management. Bisphosphonate therapy represents a significant welfare advance since it addresses the bone remodeling process causing navicular pain rather than simply blocking pain signaling as neurectomy does. Horses treated with bisphosphonates show demonstrable improvement in force plate measurements and behavioral indicators of pain, with duration of effect ranging from months to over a year. Neurectomy, while providing dramatic pain relief, creates welfare obligations since the horse cannot feel the bottom of its foot and may sustain undetected injuries. Combining bisphosphonate therapy with appropriate corrective farriery and rehabilitation exercise optimizes welfare outcomes for affected horses. The shift from management by nerve block to management by understanding specific pathology through MRI represents genuine welfare progress.